Background/Objectives: Physical activity (PA) protects against a wide range of diseases. Engagement in 23 habitual PA has been shown to be heritable, motivating the search for specific genetic variants that may 24 ultimately inform efforts to promote PA and target the best type of PA for each individual. 25 Subjects/Methods: We used data from the UK Biobank to perform the largest genome-wide association 26 study of PA to date, using three measures based on self-report (n=277,656) and two measures based on 27 wrist-worn accelerometry data (n=67,808). We examined genetic correlations of PA with other traits and 28 diseases, as well as tissue-specific gene expression patterns. With data from the Atherosclerosis Risk in 29
Introduction 43
A physically active lifestyle has been shown to protect against a wide range of diseases, including 44 cardiovascular disease, cancer, type-2 diabetes, osteoporosis, and Alzheimer's disease [1] [2] [3] [4] . Levels of 45 engagement in physical activity (PA) vary across individuals, and most people do not meet recommended 46 levels to achieve health benefits. Although cultural, economic, and other environmental factors influence 47 PA engagement 5,6 , genetic factors also likely play a role. Understanding the genetic factors underlying 48 inter-individual variation will better inform efforts to promote PA and potentially allow targeting the best 49 type of PA for each person, what might be called "Precision Exercise Prescription". 50
Evidence of genetic factors underlying the propensity to exercise in humans has been 51 demonstrated in a number of studies 7-14 . Several studies have utilized a candidate gene approach to 52 identify specific genetic variants associated with a proclivity towards PA 8, [15] [16] [17] [18] [19] . This work generally 53 focused on genes related to the serotonin and dopamine systems, energy metabolism, and neurotrophic 54 factors. However, to our knowledge there have been only two previous reports of genome-wide 55 association studies (GWAS) of PA 20,21 , neither of which identified a locus at genome-wide significance, 56 likely due to relatively small sample sizes. Thus, while previous work strongly suggests a genetic basis 57 for engagement in PA, the genes that contribute to this healthy lifestyle behavior remain unknown. 58
In this study, we conduct the largest GWAS of PA to date, aiming to identify genetic variants 59 associated with self-reported and accelerometry-based levels of habitual, leisure-time PA. We sought to 60 identify variants in the UK Biobank, a large cohort study of 500,000 adults measured across a wide range 61 of characteristics including genome-wide markers. We then examined the genetic correlation of PA with 62 other traits, examined putative tissues where PA genes may exert their effects, and meta-analyzed the 63 identified loci for MVPA with data on self-reported PA in an independent cohort from the Atherosclerosis
Methods 67
Studies 68
Data from the UK Biobank study were used for discovery of variants. Briefly, the UK Biobank is 69 a large prospective cohort study of approximately a half-million adults (ages 40-69) living in the United 70 Kingdom (UK), recruited from 22 centers across the UK 22 . All participants provided written informed 71 consent. We also used data from the ARIC study, which is a prospective cohort study of over 15,000 72 adults aged 45-64 years that took place in four United States communities. Details of the ARIC study can 73 be found elsewhere 23 . To reduce the potential for confounding by population stratification, we included 74 only individuals of white race/ethnicity in both studies. 75
76

Physical activity 77
In the UK Biobank, self-reported levels of physical activity during work and leisure time were 78 measured via a touchscreen questionnaire, in a fashion similar to the International Physical Activity 79 Questionnaire 24 . For moderate PA (MPA), participants were asked: "In a typical WEEK, on how many 80 days did you do 10 minutes or more of moderate physical activities like carrying light loads, cycling at 81 normal pace? (Do not include walking)". For vigorous PA (VPA), participants were asked: "In a typical 82 WEEK, how many days did you do 10 minutes or more of vigorous physical activity? (These are 83 activities that make you sweat or breathe hard such as fast cycling, aerobics, heavy lifting)". For each of 84 these questions, those who indicated 1 or more such days were then asked "How many minutes did you 85 usually spend doing moderate/vigorous activities on a typical DAY". Participants were asked to include 86 activities performed for work, leisure, travel and around the house. We excluded individuals who selected 87 "prefer not to answer" or "do not know" on the above questions, those reporting not being able to walk, 88 and individuals reporting more than 16 hours of either MPA or VPA per day. Those reporting >3hr/day of 89 VPA or MPA were recoded to 3 hours, as recommended 25 . Moderate-to-vigorous PA (MVPA) was 90 modification of the Baecke questionnaire 29,30 . The sport/exercise index is based on responses to 4 items: 115 frequency of participation in sports/exercise; frequency of sweating during sports/exercise; a subjective 116 rating of the frequency of participation in sports/exercise compared to others in the same age group; the 117 sum of frequency, duration, and intensity of up to 4 sports/exercises. 118
119
Genotypes 120
The majority of UK Biobank participants were genotyped with the Affymetrix UK Biobank 121
Axiom Array (Santa Clara, CA, USA), while 10% of participants were genotyped with the Affymetrix 122 UK BiLEVE Axiom Array. Detailed quality control and imputation procedures are described elsewhere 123 31 . Imputation was performed using a combined panel of the Haplotype Reference Consortium 32 and the 124 UK10K haplotype resource 33 . Since corrections for potential problems with the position assignment of 125 the SNPs from the UK10K haplotype resource were not available at the time of analysis, we only 126 included SNPs imputed from the Haplotype Reference Consortium. To minimize the possibility of 127 confounding due to population stratification, only participants who self-identified as White/British 128 (European-descent), and who were not population outliers based on principal components analysis (PCA) 129 were included. Individuals were excluded based on unusually high heterozygosity or >5% missing rate, a 130 missingness > 10%, and SNPs out of Hardy-Weinberg equilibrium (p<1 x 10 -6 ), and excluding individuals 139 with SNP missingness > 10%. We used principal components for the European-ancestry group as 140 provided by ARIC in dbGaP. Briefly, LD pruning resulted in 71,702 SNPs that were used to derive 141 principal components. A total sample size of 8,556 participants was used in the analysis. 142 143
Statistical analyses 144
For the continuous variables in the UK Biobank (MVPA and accelerometry variables) we created 145 an adjusted phenotype corresponding to the residual of the regression of the following independent 146 variables on the respective dependent PA variable: age, sex, genotyping chip, first ten genomic principal 147 components, center, season (month) at center visit or wearing accelerometer (coded 0 for Winter, 1 for 148 Fall or Spring, and 2 for Summer). In sensitivity analyses, we considered the inclusion of the additional 149 following covariates: levels of physical activity at work (coded as 0 by default, 1 for 'sometimes', 2 for 150 'usually', and 3 for 'always'), extent of walking or standing at work (coded similarly as previous 151 variable), and the Townsend Deprivation Index (TDI; a composite measure of deprivation as previously 152 described 35, 36 ). We also considered a third model in which body mass index (BMI) was included as an 153 additional covariate. Since the MVPA and fraction of accelerations > 425 mg variables exhibited skewed 154 distributions, we inverse-normalized these variables prior to inclusion in the models. Model residuals 155 conformed to the assumptions of normality and homoscedasticity. For the categorical variables, we used 156 logistic regression, including the same set of covariates listed above. We also sought to identify variants 157 consistently associated with PA across all five measures. We thus searched for variants associated in the 158 same direction, with p<0.001 with each of the five PA phenotypes. The prior probability under the null 159 hypothesis for a SNP association at this level with all four phenotypes and with the same direction of association is 0.005 × 0.0025 4 = 1.95 × 10 -13 . However, it is important to note that these five phenotypes 161 are correlated with each other. 162
Given the association that we identified with the rs428358 variant in APOE (see results below), 163
we performed two additional analyses. First, we examined the associations with the APOE 4 genotype, 164 using this SNP along with the rs7412 SNP. Individuals with homozygous CC genotypes at both of these 165
SNPs were classified as homozygous for the APOE 4 allele. Individuals with homozygous CC genotypes 166 at either SNP and heterozygous at the other SNP were classified as being heterozygous for the 4 allele. 167
We excluded individuals heterozygous at both SNPs. We assumed an additive model in association 168 testing. Second, to examine whether this association may be driven by individuals with a known family 169 history of Alzheimer's disease increasing their levels of PA, we examined the association of a binary 170 variable indicating any self-reported first-degree family history (mother, father, or siblings) of 171 Alzheimer's disease or dementia with MVPA. 172
All genome-wide significant loci for MVPA were examined in ARIC, where we modeled PA as a 173 continuous variable (as described above). We used multiple linear regression to model PA as a function 174 of: age, sex, first ten genomic principal components, BMI, center, season (coded in the same way as 175 described above). Residuals from this model conformed to the assumptions of normality and 176 homoscedasticity. They were standardized to have a mean of 0 and standard deviation of 1, and were used 177 as the outcome in the genome-wide SNP association analysis. We performed meta-analysis of the top hits 178 for MVPA in the UK Biobank with the corresponding SNP association results in ARIC, using fixed-179 effects inverse-variance weighted meta-analysis. All GWAS analyses were performed with PLINK 2.0, 180
assuming an additive genetic model 37 . Additional analyses were performed with R statistical software 38 . 181
To examine association of genetic variants with gene expression patterns in different tissues, we used the 182 web-based platform, Functional Mapping and Annotation of Genome-Wide Association Studies (FUMA 200 traits and diseases using LD score regression 41,42 , implemented in an online interface 186 (http://ldsc.broadinstitute.org/). The genetics of these other traits and diseases are inferred from 187 previously published GWAS. A significant genetic correlation was considered to have a p< 2.5 × 10 -4 , 188 assuming a correction for 200 different tests, which is conservative given that many of the traits/diseases 189 tested are correlated with each other. LD score regression intercepts and chip heritability estimates were 190 also recorded. 191
192 Results 193
Self-reported PA in UK Biobank 194
A summary of self-report PA variables can be found in Table 1 . BMI and TDI were consistently 195 negatively associated with these variables, whereas warmer season and male gender were consistently 196 positively associated with them (see Supplementary Table 1 ). Physical activity at work was positively 197 associated with MVPA and VPA, and negatively associated with SSOE. Self-report PA measures were 198 weakly correlated with accelerometry-based measures (see Supplementary Table 2 ). 'Chip heritability' 199 estimates for self-report PA measures were approximately 5-6% ( Supplementary Table 3 ). LD score 200 regression intercepts (<1.02) suggest no significant systematic inflation of test statistics. In over 277,000 201 individuals, we found ten loci significantly associated (p < 5 × 10 -8 ) with MVPA and four loci with VPA 202 (see Figure 1 and Table 2 ). Most notably, the C allele at SNP rs429358 in APOE is associated with higher 203 self-reported MVPA. This allele is also nominally associated with higher levels of other PA measures 204 (VPA: p=8.4 × 10 -6 ; SSOE: p=0.049; average acceleration: p=3.7 × 10 -3 ). Testing the association of the 205
Alzheimer's disease-related APOE 4 allele with MVPA resulted in nearly identical findings. In models 206 adjusted for other covariates, this APOE variant remained genome-wide significant (see Supplementary  207 Tables 4 and 5). There were 33,337 individuals reporting any family history of Alzheimer's disease or 208 dementia among parents and siblings. These individuals reported lower levels of MVPA (p=1.2 × 10 -4 ). 209
An intronic variant in CADM2 was associated with SSOE (see Table 2 ). A variant at the same locus was 210 also associated with VPA in the model including all covariates (see Suppl. Table 5 ). Variants in and near 211 MMS22L were identified with VPA and SSOE, respectively. Upon meta-analysis of the 10 top hits for 212 MVPA with the results in ARIC, 8 were genome-wide significant (p<5 × 10 -8 ), including the APOE 213 variant (see Table 3 ). In models adjusting for additional covariates (PA at work, TDI, BMI), the results 214 were similar, but with fewer loci reaching genome-wide significance (see Supplementary Tables 4 and 5  215 and Supplementary Figures 1 and 2) . Notably, the APOE and CADM2 loci remained significant after 216 adjustment for other covariates. 217
218 Accelerometer-based PA in UK Biobank 219 'Chip heritability' estimates for the accelerometry-based measures were higher (15% for average 220 acceleration, and 11% for fraction of accelerations >425 mg) than for self-report PA measures 221
( Supplementary Table 3 ). LD score regression intercepts (<1.009) suggest no significant systematic 222 inflation of test statistics. Three loci were found to be significantly associated with average acceleration 223 and one locus with fraction of accelerations >425 mg (see Table 2 and Figure 1 ). In models adjusted for 224 other covariates, only the MAPT_AS1 locus remained consistently genome-wide significant (see 225 Supplementary Tables 4 and 5 and Supplementary Figures 1 and 2) . 226
We found thirteen loci associated with each of the five PA measures at p<0.005, and with the 227 same direction of association (Table 4 ). These include an intronic variant in DNAJC1, a variant just 228 upstream of DCAF5, and a missense variant in PML. 229 found highly significant negative genetic correlations of MVPA and VPA with intelligence (see Figure 2 ). 233
We also found significant positive genetic correlations with early-morning chronotype and schizophrenia. 234
Interestingly, however, we found a positive correlation of SSOE with years of schooling and intelligence, 235 as well as with age at first birth and bipolar disorder. SSOE was negatively genetically correlated with 236 depressive symptoms, neuroticism, body fat, waist circumference, and insomnia (see Figure 2 ). Among 237 the accelerometry-based variables, we found highly significant negative genetic correlations of PA with 238 waist and hip circumference, body fat, obesity, BMI, and triglycerides (see Figure 2 ). Genetic correlation 239 results remained very similar with GWAS models including activity at work and TDI as covariates (see 240 Supplementary Figure 3) , except for generally attenuated correlations with intelligence in the model with 241 all covariates except BMI. Upon addition of BMI as a covariate, the direction of genetic correlation 242 between PA and obesity traits was reversed (see Supplementary Figure 4 ). As we note below, caution 243 may be warranted in interpreting results from these adjusted models. In ARIC, we found similar genetic 244 correlations of PA with waist circumference (r g =-0.13), chronotype (r g =0.04), years of schooling 245 (r g =0.16), and schizophrenia (r g =0.32), although these do not reach statistical significance. 246
Tissue enrichment analysis using eQTL data from GTEx implicate the brain and pituitary gland 247 as primary tissues through which the PA-associated loci may exert their effects (see Figure 3 and 248 Supplementary Figures 5 and 6) . Given the importance of PA for many dimensions of health, and its' reported heritability, we 252 sought to identify genetic variants that are associated with engagement in habitual physical activity, while 253
considering important covariates such as season, physical activity at work, socio-economic status, and over 25 genome-wide significant SNPs. Although most were novel, some had previous links to disease or 257 other traits. Among these, the variant in CADM2, a gene which encodes cell adhesion molecule 2, and is 258 primarily expressed in the brain, has recently been linked to risk-taking behavior and other personality 259 traits 43-45 , as well as with information processing speed 46 . The A allele at rs1376935 that we found to be 260 associated with higher SSOE, is in LD in the European population with the G allele at the rs13084531 261 SNP which was found to be associated with risk-taking behavior 45 . It thus appears that this locus may be 262 important for several personality, cognitive, and behavioral traits, and may potentially be involved in 263 reward systems. Additionally, it is important to note that this locus was significant for SSOE but not for 264 the other traits. It may thus be specifically implicated in the proclivity to engage in intentional high-265
intensity exercise and sport, as opposed to more general and/or lower intensity PA. 266
Interestingly, a well-established variant in APOE (part of APOE ε4 allele), strongly implicated in 267
Alzheimer's disease 47,48 , exhibited one of the strongest associations with PA, and remained significant 268 upon meta-analysis. How the APOE risk allele is associated with greater PA is not clear. An exercise 269 training study found that APOE 4 carriers had a greater increase in aerobic capacity 49 . This increased 270 responsivity to PA could reinforce engagement in PA or be related to other factors that influence the 271 tendency to engage in PA. Although another potential explanation for our finding is that individuals with 272 a known family history of dementia or Alzheimer's disease purposefully increase their levels of PA in the 273 hope of reducing risk for developing the disease, our findings do not suggest that individuals with a first-274 degree family history of Alzheimer's disease or dementia engage in higher levels of PA. It is important to 275 note that the association between APOE and PA may lead to spurious gene-environment interactions 50 , 276 and thus further work is needed to clarify this observed association. Additionally, although the association 277 remained after adjustment for BMI and other covariates, it remains to be determined whether some 278 residual confounding might exist. Finally, it is important to note that none of the identified loci have 279 previously been found to be associated with PA or related traits 16, 17 . 51, 52 . Similarly, we found an overall shared genetic basis for PA (especially accelerometer-based 282 measures) with several obesity-related traits, suggesting that genetic risk for obesity coincides with 283 genetic propensity for lower PA. There is likely a complex set of genetic, environmental, and phenotypic 284 factors that connect PA and obesity across the lifespan, that involve many pleiotropic genetic factors. 285
Although the direction of correlation is reversed when BMI is included as a covariate, caution is 286 warranted in interpreting results of genetic associations in which heritable covariates are included in the 287 association model 53 . Another major potential source of bias is collider bias, which occurs when one 288 controls for a variable (i.e. BMI) that is caused by both another covariate (i.e. gene) and the outcome 289 variable in the model (i.e. PA) 54, 55 . 290
Our study is strengthened by the large sample size, the availability of both self-reported and 291 objective accelerometer-based measures of PA, and the availability of a replication cohort from a 292 different country. However, we note several limitations. Given the relatively small genetic effect sizes 293 observed for these PA phenotypes, we were insufficiently powered to formally replicate associations in 294 the much smaller sample size in ARIC. Additional replication studies are thus needed to more robustly 295 identify PA-associated loci. Furthermore, the self-report measures of PA used in ARIC differed from the 296 one used in the UK Biobank. Both self-reported and accelerometer-based measures of PA are subject to 297 various biases. Since both the UK Biobank and ARIC cohorts are comprised of middle-to late-middle-298 aged adults, the extent to which these results generalize to other age groups is not known. Furthermore, 299 our results may not generalize to other ethnic/racial groups. 300
In conclusion, our study revealed several important new findings. Effect sizes were generally 301 very small, given the very large sample size, the common variants identified, and the modest p-values. 302
We identified over 20 variants, most of which were novel, and thus need further study. We identified a 303 variant in CADM2, a gene previously been found to be associated with personality traits. We also with higher levels of PA, suggesting the need for follow up studies to help clarify the nature of this 306 observed association and its implication for understanding gene-environment interactions related to PA. 307
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